Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Therapeutic Supply (Ibogaine/Neuroplastogens)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract under the Advanced Research Projects Agency for Health (ARPA-H) involves the manufacture and supply of clinical-grade active pharmaceutical ingredients or formulated drug products, specifically ibogaine or neuroplastogen-based therapeutics. The selected provider must support prime contractors on ASCENT-IBO projects by delivering pharmaceutical-grade compounds suitable for human trials. A critical requirement for this contract is the maintenance of Good Manufacturing Practice (GMP) certification to ensure all products meet strict clinical grade standards. The opportunity was posted on August 5, 2026, with a response deadline of October 15, 2026, falling under NAICS code 325412.

General Info

Subcontract for GMP clinical-grade ibogaine or neuroplastogen therapeutics for ARPA-H ASCENT-IBO projects.

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

DC, USA

Set-Aside

NONE

Documents

This scope was carved out of ARPA-H-SN-26-158.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Area of Interest under PHO ISO: ASCENT-IBO

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies active pharmaceutical ingredients (API) or formulated drug products for prime contractors on ARPA-H ASCENT-IBO projects. Manufactures and supplies ibogaine or neuroplastogen-based therapeutics meeting clinical grade standards. Requires GMP (Good Manufacturing Practice) certification and the ability to provide pharmaceutical-grade compounds for human trials. Delivers clinical-grade neuroplastogen/ibogaine drug product.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541715
New
Federal
Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program
Solicitation # 7599226SN106
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals from small business concerns (SBCs) for its Fiscal Year 2026 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The program aims to stimulate technological innovation and increase private sector commercialization of federal research and development. Eligible participants must be for-profit businesses located in the United States with no more than 500 employees. The solicitation focuses on seven high-impact research topics: the development of an annual fertility test, versatile bioadhesives, a universal platform for living adaptive toxin-removal, non-surgical therapies for endometriosis, rapid diagnostics for multi-system autoimmune disease, a virtual human brain for neurosurgical robotics, and the ARPA-H Lineage topic for advancing previously funded technologies. The submission process is structured in two stages. Stage 1 requires a Solution Summary, SBA proof of registration, and various certifications. Stage 2 involves a more detailed submission including a technical presentation, a Task Description Document, a cost proposal, and a key personnel worksheet. Awards are based on technical merit, novelty, team experience, and the path to health outcomes, subject to funding availability and security risk assessments. The program utilizes fixed payment milestones and provides additional Technical and Business Assistance (TABA) funding of up to 6,500 dollars for Phase I and 50,000 dollars for Phase II projects. All proposers must maintain an active SAM.gov registration and adhere to strict marking requirements for proprietary technical data.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 23 hours ago

DEADLINE

in 19 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS